ATE215958T1 - Adenosin-derivate - Google Patents
Adenosin-derivateInfo
- Publication number
- ATE215958T1 ATE215958T1 AT97923051T AT97923051T ATE215958T1 AT E215958 T1 ATE215958 T1 AT E215958T1 AT 97923051 T AT97923051 T AT 97923051T AT 97923051 T AT97923051 T AT 97923051T AT E215958 T1 ATE215958 T1 AT E215958T1
- Authority
- AT
- Austria
- Prior art keywords
- 3alkyl
- pct
- date nov
- nitrogen
- nrarb
- Prior art date
Links
- 150000003835 adenosine derivatives Chemical class 0.000 title abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910003827 NRaRb Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 108010060263 Adenosine A1 Receptor Proteins 0.000 abstract 1
- 102000030814 Adenosine A1 receptor Human genes 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9610031.8A GB9610031D0 (en) | 1996-05-14 | 1996-05-14 | Chemical compounds |
| PCT/EP1997/002403 WO1997043300A1 (en) | 1996-05-14 | 1997-05-13 | Adenosine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215958T1 true ATE215958T1 (de) | 2002-04-15 |
Family
ID=10793664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97923051T ATE215958T1 (de) | 1996-05-14 | 1997-05-13 | Adenosin-derivate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5998388A (de) |
| EP (1) | EP0901499B1 (de) |
| JP (1) | JP2001503382A (de) |
| AT (1) | ATE215958T1 (de) |
| AU (1) | AU2896197A (de) |
| DE (1) | DE69711868T2 (de) |
| ES (1) | ES2175405T3 (de) |
| GB (1) | GB9610031D0 (de) |
| WO (1) | WO1997043300A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9723566D0 (en) | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| GB9723589D0 (en) | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| GB9723590D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
| IL127947A0 (en) * | 1999-01-07 | 1999-11-30 | Can Fite Technologies Ltd | Pharmaceutical use of adenosine agonists |
| US6790839B2 (en) | 1999-01-07 | 2004-09-14 | Can-Fite Biopharma Ltd. | Pharmaceutical administration of adenosine agonists |
| WO2002004474A1 (en) * | 2000-07-12 | 2002-01-17 | Nikken Chemicals Co. Ltd. | Adenosine compound and pharmaceutical composition containing the same |
| GB2372742A (en) * | 2001-03-03 | 2002-09-04 | Univ Leiden | C2,5'-Disubstituted and N6,C2,5'-trisubstituted adenosine derivatives and their different uses |
| GB0105469D0 (en) * | 2001-03-06 | 2001-04-25 | Glaxo Group Ltd | Medicaments |
| GB0106867D0 (en) * | 2001-03-20 | 2001-05-09 | Glaxo Group Ltd | Process |
| US6995148B2 (en) * | 2001-04-05 | 2006-02-07 | University Of Pittsburgh | Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy |
| CN101712709A (zh) * | 2008-10-06 | 2010-05-26 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷及其调血脂的用途 |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55160797A (en) * | 1979-05-31 | 1980-12-13 | Ajinomoto Co Inc | Purine nucleoside derivative |
| US5219840A (en) * | 1987-04-06 | 1993-06-15 | Sandoz Ltd. | Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives |
| DK62592D0 (de) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| AU4772493A (en) * | 1992-07-15 | 1994-02-14 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Sulfo-derivatives of adenosine |
| DK155292D0 (da) * | 1992-12-23 | 1992-12-23 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| US5688774A (en) * | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| AU7331094A (en) * | 1993-07-13 | 1995-02-13 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | A3 adenosine receptor agonists |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| AU2022597A (en) * | 1996-03-13 | 1997-10-01 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
-
1996
- 1996-05-14 GB GBGB9610031.8A patent/GB9610031D0/en active Pending
-
1997
- 1997-05-13 ES ES97923051T patent/ES2175405T3/es not_active Expired - Lifetime
- 1997-05-13 WO PCT/EP1997/002403 patent/WO1997043300A1/en not_active Ceased
- 1997-05-13 JP JP54050397A patent/JP2001503382A/ja not_active Ceased
- 1997-05-13 US US09/180,442 patent/US5998388A/en not_active Expired - Fee Related
- 1997-05-13 AT AT97923051T patent/ATE215958T1/de not_active IP Right Cessation
- 1997-05-13 DE DE69711868T patent/DE69711868T2/de not_active Expired - Lifetime
- 1997-05-13 EP EP97923051A patent/EP0901499B1/de not_active Expired - Lifetime
- 1997-05-13 AU AU28961/97A patent/AU2896197A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US5998388A (en) | 1999-12-07 |
| GB9610031D0 (en) | 1996-07-17 |
| WO1997043300A1 (en) | 1997-11-20 |
| JP2001503382A (ja) | 2001-03-13 |
| DE69711868D1 (de) | 2002-05-16 |
| ES2175405T3 (es) | 2002-11-16 |
| EP0901499A1 (de) | 1999-03-17 |
| DE69711868T2 (de) | 2002-10-10 |
| EP0901499B1 (de) | 2002-04-10 |
| AU2896197A (en) | 1997-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901820A2 (hu) | 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra | |
| NO982330L (no) | Pyrazolderivater, fremgangsmÕte for fremstilling derav og farmas°ytiske preparater inneholdende nevnte derivater | |
| HUP0203438A2 (hu) | Foszfodiészteráz gátló hatású 5-(2-helyettesített-5-heterociklilszulfonilpirid-3-il)-dihidropirazolo[4,3-d]-pirimidin-7-on-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| ATE152443T1 (de) | Anilide-derivate | |
| BG108420A (en) | New indole derivatives with 5-ht6 receptor affinity | |
| ATE331726T1 (de) | Adenine-derivate | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
| ATE390421T1 (de) | Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen | |
| ITRM20010356A1 (it) | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. | |
| HUP0204143A2 (en) | Tricyclic 1-benzylpyrazoles-3-carboxylic acid derivatives, preparation of the compounds, their use and pharmaceutical compositions containing them | |
| DE69711868D1 (de) | Adenosin-derivate | |
| AR009938A1 (es) | Nuevos derivados de arilglicinamida, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos | |
| ES2108717T3 (es) | Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| PT902684E (pt) | Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos | |
| DK173684D0 (da) | Bicylooxyarylthiourinstoffer og fremgangsmaade til fremstilling heraf | |
| AR017146A1 (es) | Compuestos de 1-(fenil-sustituido)-5-(4-metilsulfonilfenil)pirazol; procedimiento para prepararlos, las composiciones farmaceuticas que los contienen,los agentes inhibidores de la cox-ii que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos. | |
| ATE337827T1 (de) | N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| DK0765322T3 (da) | Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister | |
| NO954316L (no) | Benzo(f)kinoksalidinonderivater, deres fremstilling og anvendelse i legemidler | |
| IT1286141B1 (it) | Derivati diammidici dell'acido antranilico ad attivita' antigastrinica procedimento per la loro preparazione e loro uso farmaceutico. | |
| HUP0003555A2 (hu) | Gombaellenes hatású triazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és intermedierjük | |
| EE9900238A (et) | Difenüülalküültetrahüdropüridiinid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon | |
| ES487971A1 (es) | Procedimiento para la preparacion de nuevos derivados de p-cloroacetofenona oxima con actividad analgesica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |